The Nurse View.

Slides:

Advertisements

Similar presentations

Individualizing Treatment Options in Advanced ER-Positive Breast Cancer.

Advertisements

Perspectives on Managing Polycythemia Vera for the Nurse Practitioner and Physician Assistant.

Evolving Paradigms in Recurrent/Metastatic SCCHN

The Nurse View.

Introduction. TREATMENT BASED ON TUMOR SIDEDNESS IN mCRC: THE EVIDENCE AND PRACTICAL APPLICATION.

Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.

Introduction to medical Terminolog MEDICAL TERMINOLOGY.

The Nurse View: Hormone Receptor-Positive Advanced Breast Cancer

209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.

What to Do Next: Sequencing of Therapy in Patients With Metastatic CRC

Advanced NSCLC Without Actionable Mutations

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

Thrombosis, Cancer, and NOACs

Glaucoma Progression.

Discussion Outline Cells of the Immune System.

The Nurse View.

Progression After Cancer Immunotherapy in Advanced NSCLC

Introduction to Checkpoint Inhibitors

Improving Acne Outcomes

The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer

Managing Hereditary Angioedema

Individualizing Prophylaxis in Hemophilia

The Nurse View: Updates in the Management of Metastatic Colorectal Cancer.

Optimizing Outcomes in the Management of GIST

Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.

Determining the Best Treatment Algorithm for Patients With Head and Neck Cancer.

Clinical Considerations in Evidence-based Management of GIST

Chronic Idiopathic Urticaria

THE CONTINUUM OF CARE IN mCRC: OPTIMIZING USE OF EGFR ANTIBODIES

A Focus on Polycythemia Vera for Nurse Practitioners and Physician Assistants.

Updates in Pulmonary Arterial Hypertension

Optimizing Management of Advanced Bladder Cancer

Best Practices in Metastatic Colorectal Cancer

The Nurse View: Targeted Therapies for the Patient With Metastatic Colorectal Cancer.

From Symptom Management to Communication in Advanced GI Cancers

Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Genitourinary Tract.

The Emerging Role of Immunotherapy in Hodgkin Lymphoma

EHL Technologies in Hemophilia Care

A Better Solution For Cancer Patients With VTE?

Essential Concepts in the Use of Immunotherapies in Bladder Cancer

Charting Progress in MS Treatment:

Perspectives on the Impact of Inflammation in OA

Improving Outcomes in Psoriatic Arthritis

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Key Questions for nAMD Treatment Success

The Road to Quality Improvement in HER2-Positive Breast Cancer

Hormone Receptor-Positive Advanced Breast Cancer Introduction

Cancer-Associated Thrombosis

The Changing Field of Melanoma: Ipilimumab.

Oral Prostacyclin Pathway Agents in PAH

Diagnosis, Evaluation, and Therapy for Severe Refractory Eosinophilic Asthma.

Incorporating Prostacyclins Into Practice

Challenges in LA SCCHN.

Maximizing Organ Protection in Patients With CKD and Comorbidities on RAAS Therapy.

Factor Xa Inhibitors in Coronary Artery Disease

The Patient With Early Stage MF-CTCL

THE CONTINUUM OF CARE IN mCRC: OPTIMIZING USE OF EGFR ANTIBODIES

Managing Pain in the 21st Century

Optimizing Front-Line Endocrine Therapy in Metastatic Breast Cancer

Clinical Considerations in Evidence-based Management of GIST

The Nurse View: Spotlight on EGFR-Mutated NSCLC

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.

Maximizing Disease-Free Survival in Early-Stage HER2-Positive Breast Cancer.

What's New in Oral Combination Therapy for Type 2 Diabetes?

Immune Checkpoint Inhibitors in Lung Cancer

The Nurse View.

Updates in Best Practices in Non-Small Cell Lung Cancer

Psoriatic Arthritis.

Presentation transcript:

The Nurse View

Introduction to Colorectal Cancer

Recommended Third-Line Therapies for Progressive mCRC

Nurse Roles in Managing AEs

Common Terminology Criteria for AEs

Common AEs With Regorafenib

Pattern of AEs With Regorafenib

Variation in Regorafenib Dosing

ReDOS Trial Weekly Escalation of Regorafenib—Design

ReDOS Trial Weekly Escalation of Regorafenib—Results

Common AEs With Trifluridine + Tipiracil (TAS-102)

Managing AEs of TAS-102

AEs With Immunotherapeutic Agents

Managing Immune-Mediated AEs of Immunotherapeutic Agents

Nurses Are Best Choice to Manage Many AEs

Useful Visual Aids

Keep in Touch With Patients Who Are Receiving Oral Oncolytic Therapy

Summary

Abbreviations